Project Grant HT9425261E417
Award Date 9/1/26
Completion Date 8/31/28
Dollars Obligated $140K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Defense Health Agency awarded The Washington University $769,999 on August 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research on control of dendritic cell dysfunction induced by gamma-delta regulatory T cells for melanoma immunotherapy. The award funds a three-year project period running through July 31, 2029, with performance in University City, Missouri. The recipient organization is the Office of Sponsored Research Services Division of...
- The Defense Health Agency awarded The Washington University Office of Sponsored Research Services $140,000 on September 1, 2026, to conduct spatial profiling of myeloid cells in the tumor immune microenvironment of primary and metastatic medullary thyroid carcinomas under the Military Medical Research and Development program (CFDA 12.420). Work is performed in University City, Missouri, with an anticipated completion date of August 31, 2028. The project falls within the Defense Health Agency's...
- The Defense Health Agency awarded The Washington University $840,000 on June 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate hyperphosphorylation of tau serine 262 as a novel biomarker and therapy target in amyotrophic lateral sclerosis (ALS). Work is performed in University City, Missouri, with a period of performance through May 31, 2028. The award supports basic and applied biomedical research to transform health care for Service Members and...
- The Defense Health Agency (DHA) awarded the University of Washington a $543,285 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2028. This award supports research focused on transforming rhabdomyosarcoma treatment through the development and evaluation of new FDA-approved combination therapies. The project will be conducted at the University of Washington's Seattle, Washington location under the...
- The Defense Health Agency awarded The Washington University $699,751 under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2026, to investigate mechanisms and develop innovative therapies for ESR1-CCDC170 fusions in clinically aggressive, endocrine-resistant, and metastatic breast cancers. The award runs through April 30, 2029, with work performed in University City, Missouri. Washington University's Office of Sponsored Research Services administers the grant as the...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $894,125 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Understanding and Targeting Epigenetic Vulnerabilities in NF-1-MPNST." The three-year award, effective from July 15, 2025 through July 14, 2028, funds advanced biomedical research investigating epigenetic mechanisms and...
- The Defense Health Agency awarded the University of Pittsburgh $1,462,665 on July 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate the intratumoral microbiome in acral melanoma. The three-year project runs through June 30, 2029, and is performed in Pittsburgh, Pennsylvania. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American...
- The Defense Health Agency awarded The Washington University a $155,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, to investigate the pathophysiologic effects of an obesogenic diet in neurofibromatosis type 1 and its impact on tumor formation. The two-year research initiative, scheduled for completion by September 29, 2027, will be conducted at the university's Office of Sponsored Research Services in University City, Missouri....
- The Defense Health Agency awarded the University of Washington $1,397,452 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research on the dynamics of eccDNA chromatin topology and molecular structures shaping glioma treatment response. Work is performed in Seattle, Washington, and runs through August 31, 2029. The University of Washington's Office of Sponsored Programs administers the award as the recipient. The Military Medical Research...